Sign in

CIK 0000939767 · Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
operating
EIN
043257395
Phone
6508377000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Open-market sale Director sold 7,712 shares at $48.45 ($373,646)
  2. 4 Open-market sale Director sold 20,634 shares at $46.00 ($949,164)
  3. 4 Open-market sale Director sold 60,000 shares at $45.71 ($2,742,600)
  4. 4 Gift President and CEO gave 109,676 shares (gift)
  5. 4 Grant or award EVP, Research and Development acquired 52,018 shares (grant or award)
  6. 4 Grant or award EVP and CFO acquired 52,018 shares (grant or award)
  7. 4 Grant or award SVP and General Counsel acquired 23,119 shares (grant or award)
  8. 4 Grant or award EVP, Commercial acquired 40,459 shares (grant or award)
  9. 4 Grant or award President and CEO acquired 160,437 shares (grant or award)
  10. 4 Open-market sale EVP, Research and Development sold 47,918 shares at $44.50 ($2,132,351)
  11. 4 Open-market sale EVP, Research and Development sold 29,873 shares at $44.35 ($1,324,868)
  12. 4 Planned sale Director sold 99,574 shares at $44.01 ($4,382,252)
  13. 4 Open-market sale Director sold 106,539 shares at an average $44.00 ($4,687,346)
  14. 4 Open-market sale EVP and CFO sold 64,895 shares at an average $43.32 ($2,810,998)
  15. 4 Open-market sale EVP, Commercial sold 67,814 shares at an average $43.52 ($2,950,941)
  16. 4 Shares withheld for taxes President and CEO gave up 489,996 shares (to pay taxes)
  17. 4 Planned sale Director sold 3,856 shares at $43.79 ($168,854)
  18. 4 Shares withheld for taxes EVP, Research and Development gave up 39,205 shares (to pay taxes)
  19. 4 Open-market sale Director sold 30,250 shares at an average $43.81 ($1,325,339)
  20. 4 Planned sale SVP and General Counsel sold 18,669 shares at $44.01 ($821,623)

Page 2 of 73 · 1,458 filings